Development of topical treatment with rapamycin for skin lesions of tuberous sclerosis complex
Development of topical treatment with rapamycin for skin lesions of tuberous sclerosis complex - Development of topical treatment with rapamycin for skin lesions of tuberous sclerosis complex Development of topical treatment with rapamycin for skin lesions of tuberous sclerosis complex - Dev ...
tuberous sclerosis complex
Application of 0.2% Rapamycin ointment (ointment base is 0.03% tacrolimus ointment) on skin lesion of one side of the face twice a day for 12 weeks. Application of ointment base (control) on similar skin lesion of the other side of the face twice a day for 12 weeks. Application of 0.2% Rapamycin ointment (ointment base is white petrolatum) on skin lesion of one side of the face twice a day for 12 weeks. Application of ointment base (control) on similar skin lesion of the other side of the face twice a day for 12 weeks. Application of 0.2% Rapamycin gel (base is carboxyvinyl polymer) on skin lesion of one side of the face twice a day for 12 weeks. Application of gel base (control) on similar skin lesion of the other side of the face twice a day for 12 weeks. Application of 0.2% Rapamycinointment (ointment base is 0.03% tacrolimusointment) on skin lesion of ...
Department of DermatologyGraduate School of Medicine, Osaka University